Insider Trades116 trades
| Date↓ | Side | Ticker↕ | Insider↕ | Role↕ | Shares↕ | Price↕ | Mkt Cap↕ | 52W High↕ | 52W Low↕ | Value↕ | % Chg↕ | Rule↕ | AI View↕ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jul 23, 2026 | Sell | IMVT | Jay S Stout | Chief Technology Officer | 2,857 | $38.69 | $7.7B | -17.75% | +156.24% | $110.5K | -1.37% | — | Stalk |
| Jul 23, 2026 | Sell | IMVT | Tiago Girao | Chief Financial Officer | 6,798 | $38.69 | $7.7B | -17.75% | +156.24% | $263.0K | -2.75% | — | Stalk |
| Jul 8, 2026 | Sell | IMVT | Tuyl Christopher Van | Chief Legal Officer | 1,206 | $39.55 | $7.7B | -17.75% | +156.24% | $47.7K | -0.33% | — | Stalk |
| Jul 8, 2026 | Sell | IMVT | Melanie Gloria | Chief Operating Officer | 2,036 | $39.55 | $7.7B | -17.75% | +156.24% | $80.5K | -0.46% | — | Stalk |
| Jul 8, 2026 | Sell | IMVT | Jay S Stout | Chief Technology Officer | 3,487 | $39.55 | $7.7B | -17.75% | +156.24% | $137.9K | -0.42% | — | Stalk |
| Jul 1, 2026 | Buy | IMVT | Eric Venker | Chief Executive Officer | 95,280 | $15.24 | $7.7B | -17.75% | +156.24% | $1.5M | +5.85% | — | Stalk |
| Jun 26, 2026 | Sell | IMVT | Tiago Girao | Chief Financial Officer | 20,000 | $27.18 | $7.7B | -17.75% | +156.24% | $543.6K | +0.00% | — | Stalk |
| Jun 26, 2026 | Sell | IMVT | Melanie Gloria | Chief Operating Officer | 17,714 | $38.31 | $7.7B | -17.75% | +156.24% | $678.6K | -3.77% | — | Stalk |
| Jun 26, 2026 | Sell | IMVT | Tuyl Christopher Van | Chief Legal Officer | 35,648 | $26.76 | $7.7B | -17.75% | +156.24% | $953.8K | +0.00% | — | Stalk |
| Jun 26, 2026 | Sell | IMVT | Jay S Stout | Chief Technology Officer | 40,000 | $38.31 | $7.7B | -17.75% | +156.24% | $1.5M | -8.51% | — | Stalk |
| Jun 18, 2026 | Sell | IMVT | Tuyl Christopher Van | Chief Legal Officer | 2,634 | $35.39 | $7.7B | -17.75% | +156.24% | $93.2K | -1.44% | — | Stalk |
| May 20, 2026 | Sell | IMVT | Melanie Gloria | Chief Operating Officer | 3,115 | $32.45 | $7.7B | -17.75% | +156.24% | $101.1K | -0.42% | — | Stalk |
| Apr 23, 2026 | Sell | IMVT | Jay S Stout | Chief Technology Officer | 2,754 | $29.62 | $7.7B | -17.75% | +156.24% | $81.6K | -1.08% | — | Stalk |
| Apr 23, 2026 | Sell | IMVT | Tiago Girao | Chief Financial Officer | 25,760 | $29.62 | $7.7B | -17.75% | +156.24% | $763.0K | -9.42% | — | Stalk |
| Apr 8, 2026 | Sell | IMVT | Tuyl Christopher Van | Chief Legal Officer | 5,165 | $24.83 | $7.7B | -17.75% | +156.24% | $128.2K | -2.74% | — | Stalk |
| Apr 8, 2026 | Sell | IMVT | Melanie Gloria | Chief Operating Officer | 8,722 | $24.83 | $7.7B | -17.75% | +156.24% | $216.6K | -3.43% | — | Stalk |
| Apr 8, 2026 | Sell | IMVT | Jay S Stout | Chief Technology Officer | 10,132 | $24.83 | $7.7B | -17.75% | +156.24% | $251.6K | -1.95% | — | Stalk |
| Apr 1, 2026 | Buy | IMVT | Eric Venker | Chief Executive Officer | 382,979 | $14.82 | $7.7B | -17.75% | +156.24% | $5.7M | +30.54% | — | Stalk |
| Mar 18, 2026 | Sell | IMVT | Tuyl Christopher Van | Chief Legal Officer | 2,877 | $24.97 | $7.7B | -17.75% | +156.24% | $71.8K | -1.92% | — | Stalk |
| Feb 25, 2026 | Sell | IMVT | Melanie Gloria | Chief Operating Officer | 3,238 | $27.85 | $7.7B | -17.75% | +156.24% | $90.2K | -0.63% | — | Stalk |
| Jan 21, 2026 | Sell | IMVT | Jay S Stout | Chief Technology Officer | 1,977 | $26.03 | $7.7B | -17.75% | +156.24% | $51.5K | -0.99% | — | Stalk |
| Jan 7, 2026 | Sell | IMVT | Jay S Stout | Chief Technology Officer | 1,203 | $26.53 | $7.7B | -17.75% | +156.24% | $31.9K | -0.30% | — | Stalk |
| Dec 18, 2025 | Sell | IMVT | Tuyl Christopher Van | Chief Legal Officer | 10,813 | $26.91 | $7.7B | -17.75% | +156.24% | $290.9K | -3.46% | — | Stalk |
| Nov 20, 2025 | Sell | IMVT | Melanie Gloria | Chief Operating Officer | 12,626 | $23.62 | $7.7B | -17.75% | +156.24% | $298.2K | -3.49% | — | Stalk |
| Oct 22, 2025 | Sell | IMVT | Jay S Stout | Chief Technology Officer | 2,520 | $19.03 | $7.7B | -17.75% | +156.24% | $48.0K | -1.24% | — | Stalk |
| Oct 22, 2025 | Sell | IMVT | Michael Geffner | Chief Medical Officer | 2,595 | $19.03 | $7.7B | -17.75% | +156.24% | $49.4K | -1.18% | — | Stalk |
| Oct 8, 2025 | Sell | IMVT | Michael Geffner | Chief Medical Officer | 1,272 | $16.30 | $7.7B | -17.75% | +156.24% | $20.7K | -0.57% | — | Stalk |
| Oct 8, 2025 | Sell | IMVT | Jay S Stout | Chief Technology Officer | 1,585 | $16.30 | $7.7B | -17.75% | +156.24% | $25.8K | -0.77% | — | Stalk |
| Jul 23, 2025 | Sell | IMVT | Michael Geffner | Chief Medical Officer | 2,385 | $18.15 | $7.7B | -17.75% | +156.24% | $43.3K | -1.06% | — | Stalk |
| Jul 23, 2025 | Sell | IMVT | Jay S Stout | Chief Technology Officer | 2,805 | $18.15 | $7.7B | -17.75% | +156.24% | $50.9K | -1.35% | — | Stalk |
| Jul 9, 2025 | Sell | IMVT | Michael Geffner | Chief Medical Officer | 1,160 | $17.24 | $7.7B | -17.75% | +156.24% | $20.0K | -0.51% | — | Stalk |
| Jul 9, 2025 | Sell | IMVT | Jay S Stout | Chief Technology Officer | 1,519 | $17.24 | $7.7B | -17.75% | +156.24% | $26.2K | -0.73% | — | Stalk |
| Apr 23, 2025 | Sell | IMVT | Jay S Stout | Chief Technology Officer | 1,925 | $14.79 | $7.7B | -17.75% | +156.24% | $28.5K | -0.91% | — | Stalk |
| Apr 23, 2025 | Sell | IMVT | Michael Geffner | Chief Medical Officer | 2,349 | $14.79 | $7.7B | -17.75% | +156.24% | $34.7K | -1.03% | — | Stalk |
| Apr 16, 2025 | Sell | IMVT | Eva Renee Barnett | Chief Financial Officer | 2,993 | $14.89 | $7.7B | -17.75% | +156.24% | $44.6K | -0.75% | — | Stalk |
| Apr 16, 2025 | Sell | IMVT | Peter Salzmann | Chief Executive Officer | 8,321 | $14.89 | $7.7B | -17.75% | +156.24% | $123.9K | -0.70% | — | Stalk |
| Apr 9, 2025 | Sell | IMVT | Jay S Stout | Chief Technology Officer | 5,004 | $12.99 | $7.7B | -17.75% | +156.24% | $65.0K | -2.31% | — | Stalk |
| Apr 9, 2025 | Sell | IMVT | Michael Geffner | Chief Medical Officer | 6,169 | $12.99 | $7.7B | -17.75% | +156.24% | $80.1K | -2.64% | — | Stalk |
| Apr 9, 2025 | Sell | IMVT | Eva Renee Barnett | Chief Financial Officer | 11,063 | $12.99 | $7.7B | -17.75% | +156.24% | $143.7K | -1.36% | — | Stalk |
| Apr 9, 2025 | Sell | IMVT | Peter Salzmann | Chief Executive Officer | 28,094 | $12.99 | $7.7B | -17.75% | +156.24% | $364.9K | -2.31% | — | Stalk |
| Feb 19, 2025 | Sell | IMVT | William L. Macias | Chief Medical Officer | 2,055 | $20.86 | $7.7B | -17.75% | +156.24% | $42.9K | -0.57% | — | Stalk |
| Feb 19, 2025 | Sell | IMVT | Eva Renee Barnett | Chief Financial Officer | 2,814 | $20.86 | $7.7B | -17.75% | +156.24% | $58.7K | -0.87% | — | Stalk |
| Feb 19, 2025 | Sell | IMVT | Peter Salzmann | Chief Executive Officer | 15,439 | $20.86 | $7.7B | -17.75% | +156.24% | $322.1K | -1.60% | — | Stalk |
| Jan 22, 2025 | Sell | IMVT | Jay S Stout | Chief Technology Officer | 2,195 | $23.59 | $7.7B | -17.75% | +156.24% | $51.8K | -1.54% | — | Stalk |
| Jan 22, 2025 | Sell | IMVT | Michael Geffner | Chief Medical Officer | 2,657 | $23.59 | $7.7B | -17.75% | +156.24% | $62.7K | -1.97% | — | Stalk |
| Jan 15, 2025 | Sell | IMVT | Eva Renee Barnett | Chief Financial Officer | 2,298 | $23.83 | $7.7B | -17.75% | +156.24% | $54.8K | -0.35% | — | Stalk |
| Jan 15, 2025 | Sell | IMVT | William L. Macias | Chief Medical Officer | 2,383 | $23.83 | $7.7B | -17.75% | +156.24% | $56.8K | -0.17% | — | Stalk |
| Jan 15, 2025 | Sell | IMVT | Peter Salzmann | Chief Executive Officer | 8,767 | $23.83 | $7.7B | -17.75% | +156.24% | $208.9K | -0.45% | — | Stalk |
| Jan 8, 2025 | Sell | IMVT | Eva Renee Barnett | Chief Financial Officer | 4,105 | $24.10 | $7.7B | -17.75% | +156.24% | $98.9K | -1.24% | — | Stalk |
| Jan 8, 2025 | Sell | IMVT | Peter Salzmann | Chief Executive Officer | 5,105 | $24.10 | $7.7B | -17.75% | +156.24% | $123.0K | -0.52% | — | Stalk |
| Nov 20, 2024 | Sell | IMVT | William L. Macias | Chief Medical Officer | 3,353 | $25.45 | $7.7B | -17.75% | +156.24% | $85.3K | -0.92% | — | Stalk |
| Nov 20, 2024 | Sell | IMVT | Mark S. Levine | Chief Legal Officer | 3,650 | $25.45 | $7.7B | -17.75% | +156.24% | $92.9K | -1.13% | — | Stalk |
| Nov 20, 2024 | Sell | IMVT | Eva Renee Barnett | Chief Financial Officer | 4,174 | $25.45 | $7.7B | -17.75% | +156.24% | $106.2K | -1.24% | — | Stalk |
| Nov 20, 2024 | Sell | IMVT | Peter Salzmann | Chief Executive Officer | 16,692 | $25.45 | $7.7B | -17.75% | +156.24% | $424.8K | -1.68% | — | Stalk |
| Oct 23, 2024 | Sell | IMVT | Jay S Stout | Chief Technology Officer | 2,740 | $29.53 | $7.7B | -17.75% | +156.24% | $80.9K | -1.89% | — | Stalk |
| Oct 23, 2024 | Sell | IMVT | Michael Geffner | Chief Medical Officer | 3,189 | $29.53 | $7.7B | -17.75% | +156.24% | $94.2K | -2.31% | — | Stalk |
| Oct 23, 2024 | Sell | IMVT | Mark S. Levine | Chief Legal Officer | 4,361 | $29.53 | $7.7B | -17.75% | +156.24% | $128.8K | -1.33% | — | Stalk |
| Oct 16, 2024 | Sell | IMVT | Mark S. Levine | Chief Legal Officer | 2,860 | $28.79 | $7.7B | -17.75% | +156.24% | $82.3K | -0.87% | — | Stalk |
| Oct 16, 2024 | Sell | IMVT | William L. Macias | Chief Medical Officer | 3,188 | $28.79 | $7.7B | -17.75% | +156.24% | $91.8K | -0.43% | — | Stalk |
| Oct 16, 2024 | Sell | IMVT | Eva Renee Barnett | Chief Financial Officer | 3,271 | $28.79 | $7.7B | -17.75% | +156.24% | $94.2K | -0.97% | — | Stalk |
| Oct 16, 2024 | Sell | IMVT | Peter Salzmann | Chief Executive Officer | 9,095 | $28.79 | $7.7B | -17.75% | +156.24% | $261.8K | -0.91% | — | Stalk |
| Oct 9, 2024 | Sell | IMVT | Peter Salzmann | Chief Executive Officer | 4,460 | $29.56 | $7.7B | -17.75% | +156.24% | $131.8K | -0.44% | — | Stalk |
| Oct 9, 2024 | Sell | IMVT | Eva Renee Barnett | Chief Financial Officer | 5,162 | $29.56 | $7.7B | -17.75% | +156.24% | $152.6K | -1.50% | — | Stalk |
| Aug 21, 2024 | Sell | IMVT | Julia G. Butchko | Chief Development Officer | 3,027 | $31.86 | $7.7B | -17.75% | +156.24% | $96.4K | -0.34% | — | Stalk |
| Aug 21, 2024 | Sell | IMVT | William L. Macias | Chief Medical Officer | 3,027 | $31.86 | $7.7B | -17.75% | +156.24% | $96.4K | -0.41% | — | Stalk |
| Aug 21, 2024 | Sell | IMVT | Mark S. Levine | Chief Legal Officer | 3,295 | $31.86 | $7.7B | -17.75% | +156.24% | $105.0K | -0.50% | — | Stalk |
| Aug 21, 2024 | Sell | IMVT | Eva Renee Barnett | Chief Financial Officer | 3,768 | $31.86 | $7.7B | -17.75% | +156.24% | $120.0K | -0.54% | — | Stalk |
| Aug 21, 2024 | Sell | IMVT | Peter Salzmann | Chief Executive Officer | 15,068 | $31.86 | $7.7B | -17.75% | +156.24% | $480.1K | -0.74% | — | Stalk |
| Jul 24, 2024 | Sell | IMVT | Jay S Stout | Chief Technology Officer | 2,813 | $27.76 | $7.7B | -17.75% | +156.24% | $78.1K | -1.90% | — | Stalk |
| Jul 24, 2024 | Sell | IMVT | Michael Geffner | Chief Medical Officer | 3,456 | $27.76 | $7.7B | -17.75% | +156.24% | $95.9K | -2.44% | — | Stalk |
| Jul 24, 2024 | Sell | IMVT | Mark S. Levine | Chief Legal Officer | 4,015 | $27.76 | $7.7B | -17.75% | +156.24% | $111.5K | -1.19% | — | Stalk |
| Jul 17, 2024 | Sell | IMVT | Mark S. Levine | Chief Legal Officer | 2,505 | $29.69 | $7.7B | -17.75% | +156.24% | $74.4K | -0.37% | — | Stalk |
| Jul 17, 2024 | Sell | IMVT | Julia G. Butchko | Chief Development Officer | 2,867 | $29.69 | $7.7B | -17.75% | +156.24% | $85.1K | -0.32% | — | Stalk |
| Jul 17, 2024 | Sell | IMVT | William L. Macias | Chief Medical Officer | 3,044 | $29.69 | $7.7B | -17.75% | +156.24% | $90.4K | -0.20% | — | Stalk |
| Jul 17, 2024 | Sell | IMVT | Eva Renee Barnett | Chief Financial Officer | 3,123 | $29.69 | $7.7B | -17.75% | +156.24% | $92.7K | -0.45% | — | Stalk |
| Jul 17, 2024 | Sell | IMVT | Peter Salzmann | Chief Executive Officer | 8,685 | $29.69 | $7.7B | -17.75% | +156.24% | $257.9K | -0.42% | — | Stalk |
| Jul 9, 2024 | Sell | IMVT | Julia G. Butchko | Chief Development Officer | 1,527 | $28.06 | $7.7B | -17.75% | +156.24% | $42.8K | -0.34% | — | Stalk |
| Jul 9, 2024 | Sell | IMVT | Peter Salzmann | Chief Executive Officer | 4,619 | $28.06 | $7.7B | -17.75% | +156.24% | $129.6K | -0.45% | — | Stalk |
| Jul 9, 2024 | Sell | IMVT | Eva Renee Barnett | Chief Financial Officer | 4,747 | $28.06 | $7.7B | -17.75% | +156.24% | $133.2K | -1.34% | — | Stalk |
| May 22, 2024 | Sell | IMVT | Mark S. Levine | Chief Legal Officer | 3,242 | $29.65 | $7.7B | -17.75% | +156.24% | $96.1K | -0.94% | — | Stalk |
| May 22, 2024 | Sell | IMVT | William L. Macias | Chief Medical Officer | 3,247 | $29.65 | $7.7B | -17.75% | +156.24% | $96.3K | -0.86% | — | Stalk |
| May 22, 2024 | Sell | IMVT | Julia G. Butchko | Chief Development Officer | 3,247 | $29.65 | $7.7B | -17.75% | +156.24% | $96.3K | -0.72% | — | Stalk |
| May 22, 2024 | Sell | IMVT | Eva Renee Barnett | Chief Financial Officer | 4,042 | $29.65 | $7.7B | -17.75% | +156.24% | $119.8K | -1.12% | — | Stalk |
| May 22, 2024 | Sell | IMVT | Peter Salzmann | Chief Executive Officer | 16,163 | $29.65 | $7.7B | -17.75% | +156.24% | $479.2K | -1.54% | — | Stalk |
| Apr 24, 2024 | Sell | IMVT | Michael Geffner | Chief Medical Officer | 3,261 | $28.90 | $7.7B | -17.75% | +156.24% | $94.2K | -2.25% | — | Stalk |
| Apr 24, 2024 | Sell | IMVT | Mark S. Levine | Chief Legal Officer | 3,963 | $28.90 | $7.7B | -17.75% | +156.24% | $114.5K | -1.14% | — | Stalk |
| Apr 24, 2024 | Sell | IMVT | Jay S Stout | Chief Technology Officer | 7,239 | $28.90 | $7.7B | -17.75% | +156.24% | $209.2K | -4.67% | — | Stalk |
| Apr 17, 2024 | Sell | IMVT | William L. Macias | Chief Medical Officer | 8,280 | $29.06 | $7.7B | -17.75% | +156.24% | $240.6K | -0.54% | — | Stalk |
| Apr 17, 2024 | Sell | IMVT | Mark S. Levine | Chief Legal Officer | 9,827 | $29.06 | $7.7B | -17.75% | +156.24% | $285.6K | -1.39% | — | Stalk |
| Apr 17, 2024 | Sell | IMVT | Julia G. Butchko | Chief Development Officer | 10,115 | $29.06 | $7.7B | -17.75% | +156.24% | $293.9K | -1.10% | — | Stalk |
| Apr 17, 2024 | Sell | IMVT | Eva Renee Barnett | Chief Financial Officer | 12,253 | $29.06 | $7.7B | -17.75% | +156.24% | $356.0K | -1.67% | — | Stalk |
| Apr 17, 2024 | Sell | IMVT | Peter Salzmann | Chief Executive Officer | 34,079 | $29.06 | $7.7B | -17.75% | +156.24% | $990.3K | -1.59% | — | Stalk |
| Apr 9, 2024 | Sell | IMVT | Julia G. Butchko | Chief Development Officer | 1,053 | $31.18 | $7.7B | -17.75% | +156.24% | $32.8K | -0.23% | — | Stalk |
| Apr 9, 2024 | Sell | IMVT | Eva Renee Barnett | Chief Financial Officer | 3,689 | $31.18 | $7.7B | -17.75% | +156.24% | $115.0K | -0.98% | — | Stalk |
| Apr 9, 2024 | Sell | IMVT | Peter Salzmann | Chief Executive Officer | 4,807 | $31.18 | $7.7B | -17.75% | +156.24% | $149.9K | -0.44% | — | Stalk |
| Feb 22, 2024 | Sell | IMVT | Mark S. Levine | Chief Legal Officer | 2,134 | $36.15 | $7.7B | -17.75% | +156.24% | $77.1K | -0.70% | — | Stalk |
| Feb 22, 2024 | Sell | IMVT | Julia G. Butchko | Chief Development Officer | 2,146 | $36.15 | $7.7B | -17.75% | +156.24% | $77.6K | -0.52% | — | Stalk |
| Feb 22, 2024 | Sell | IMVT | William L. Macias | Chief Medical Officer | 2,221 | $36.15 | $7.7B | -17.75% | +156.24% | $80.3K | -0.67% | — | Stalk |
| Feb 22, 2024 | Sell | IMVT | Eva Renee Barnett | Chief Financial Officer | 2,930 | $36.15 | $7.7B | -17.75% | +156.24% | $105.9K | -0.91% | — | Stalk |
| Feb 22, 2024 | Sell | IMVT | Peter Salzmann | Chief Executive Officer | 13,454 | $36.15 | $7.7B | -17.75% | +156.24% | $486.4K | -1.42% | — | Stalk |
| Jan 26, 2024 | Sell | IMVT | Mark S. Levine | Chief Legal Officer | 3,027 | $37.92 | $7.7B | -17.75% | +156.24% | $114.8K | -0.50% | — | Stalk |
| Jan 26, 2024 | Sell | IMVT | Michael Geffner | Chief Medical Officer | 10,101 | $37.92 | $7.7B | -17.75% | +156.24% | $383.0K | -5.31% | — | Stalk |
| Jan 18, 2024 | Sell | IMVT | William L. Macias | Chief Medical Officer | 424 | $41.03 | $7.7B | -17.75% | +156.24% | $17.4K | -0.13% | — | Stalk |
| Jan 11, 2024 | Sell | IMVT | Eva Renee Barnett | Chief Financial Officer | 3,515 | $41.83 | $7.7B | -17.75% | +156.24% | $147.0K | -0.54% | — | Stalk |
| Jan 5, 2024 | Sell | IMVT | Julia G. Butchko | Chief Development Officer | 1,297 | $38.59 | $7.7B | -17.75% | +156.24% | $50.1K | -0.32% | — | Stalk |
| Jan 5, 2024 | Sell | IMVT | Peter Salzmann | Chief Executive Officer | 3,824 | $38.59 | $7.7B | -17.75% | +156.24% | $147.6K | -0.40% | — | Stalk |
| Nov 22, 2023 | Sell | IMVT | Mark S. Levine | Chief Legal Officer | 3,252 | $32.78 | $7.7B | -17.75% | +156.24% | $106.6K | -0.53% | — | Stalk |
| Nov 22, 2023 | Sell | IMVT | William L. Macias | Chief Medical Officer | 3,265 | $32.78 | $7.7B | -17.75% | +156.24% | $107.0K | -0.49% | — | Stalk |
| Nov 22, 2023 | Sell | IMVT | Julia G. Butchko | Chief Development Officer | 3,265 | $32.78 | $7.7B | -17.75% | +156.24% | $107.0K | -0.40% | — | Stalk |
| Nov 22, 2023 | Sell | IMVT | Eva Renee Barnett | Chief Financial Officer | 4,055 | $32.78 | $7.7B | -17.75% | +156.24% | $132.9K | -0.62% | — | Stalk |
| Nov 22, 2023 | Sell | IMVT | Peter Salzmann | Chief Executive Officer | 16,217 | $32.78 | $7.7B | -17.75% | +156.24% | $531.6K | -0.85% | — | Stalk |
| Oct 25, 2023 | Sell | IMVT | Mark S. Levine | Chief Legal Officer | 4,107 | $34.66 | $7.7B | -17.75% | +156.24% | $142.3K | -1.31% | — | Stalk |
| Oct 19, 2023 | Sell | IMVT | William L. Macias | Chief Medical Officer | 530 | $36.80 | $7.7B | -17.75% | +156.24% | $19.5K | -0.16% | — | Stalk |
| Oct 10, 2023 | Sell | IMVT | Eva Renee Barnett | Chief Financial Officer | 4,557 | $36.92 | $7.7B | -17.75% | +156.24% | $168.2K | -1.36% | — | Stalk |
| Oct 5, 2023 | Sell | IMVT | Julia G. Butchko | Chief Development Officer | 1,735 | $36.24 | $7.7B | -17.75% | +156.24% | $62.9K | -0.21% | — | Stalk |
| Oct 5, 2023 | Sell | IMVT | Peter Salzmann | Chief Executive Officer | 5,239 | $36.24 | $7.7B | -17.75% | +156.24% | $189.9K | -0.27% | — | Stalk |